药明康德拟每股配售104.27港元折让约6.90%配售7380万股新H股，净筹约76.5亿港元

Group 1 - WuXi AppTec (02359) announced a placement agreement with placement agents to issue 73.8 million new H-shares at a price of HKD 104.27 per share, representing approximately 16.01% of the enlarged issued H-shares and 2.51% of the total issued shares post-placement [2] - The placement price reflects a discount of about 6.90% compared to the last trading price of HKD 112.00 per share on July 30, 2025 [2] - The net proceeds from the placement are expected to be approximately HKD 7.65 billion, with about 90% allocated for accelerating global expansion and capacity building, and about 10% for general corporate purposes [2]